FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

scientific article

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1047182994
P356DOI10.1007/S00401-010-0698-6
P932PMC publication ID2887939
P698PubMed publication ID20490813
P5875ResearchGate publication ID44619136

P50authorHazel UrwinQ114407900
Astrid AuthierQ114407901
FReJA ConsortiumQ114407902
John CollingeQ21165693
Christine Van BroeckhovenQ2247235
John Q. TrojanowskiQ6253636
William SeeleyQ8018255
Elizabeth M. C. FisherQ21259007
Rosa RademakersQ28777946
Stuart Pickering-BrownQ30003369
Janice HoltonQ30089851
Dennis W. DicksonQ30504740
Myron F. WeinerQ37370228
Jillian J. KrilQ37840325
Samir Kumar-SinghQ38329822
Julie van der ZeeQ40284433
Jonathan D RohrerQ42407224
John Van SwietenQ42684069
Peter JohannsenQ44553907
Glenda HallidayQ45304807
David G. MunozQ46312748
Han-Xiang DengQ55692589
Sebastiaan EngelborghsQ56616406
Bruce L. MillerQ56825815
Ronald C. PetersenQ56839853
Martin RossorQ56850440
Eileen H BigioQ57020324
Vivianna M Van DeerlinQ59820064
Peter Paul De DeynQ60327954
Charles L WhiteQ60638965
Manuela NeumannQ66730291
Adrian M IsaacsQ88683796
Keith A JosephsQ90859127
Neill R Graff-RadfordQ91360658
Kimmo HatanpaaQ91409013
Simon MeadQ91709870
Harro SeelaarQ92438245
P2093author name stringTamas Revesz
Ian R Mackenzie
Joseph E Parisi
Jeremy M Brown
David M Mann
Gary Adamson
Ida E Holm
Felix Geser
Shabnam Ghazi-Noori
Jorgen E Nielsen
Valerie Doodeman
P2860cites workMutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaQ24309521
Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion diseaseQ24628685
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotypeQ24642852
A new subtype of frontotemporal lobar degeneration with FUS pathologyQ24647697
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisQ28131672
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosisQ28236796
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6Q28236805
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Q28253639
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Q28253651
FUS pathology in basophilic inclusion body diseaseQ28261473
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17Q28274687
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteriaQ29614410
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinQ29619232
Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9.Q33364603
Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degenerationQ33830991
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's DiseaseQ33955976
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degenerationQ33999208
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an updateQ34020227
The role of tau (MAPT) in frontotemporal dementia and related tauopathiesQ34348115
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodiesQ35607253
Clinical and neuropathologic variation in neuronal intermediate filament inclusion diseaseQ35927831
TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusionsQ35928153
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseasesQ36452247
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK seriesQ36960858
TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD studyQ37082139
Loss of progranulin function in frontotemporal lobar degenerationQ37105126
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Q37171556
The role of CHMP2B in frontotemporal dementiaQ37368297
Rethinking ALS: the FUS about TDP-43.Q37419912
The heritability and genetics of frontotemporal lobar degeneration.Q37425094
Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlationQ38411857
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitroQ40063451
Inheritance of frontotemporal dementiaQ41679025
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendationsQ41942745
Neurofilament inclusion body disease: a new proteinopathy?Q42444985
An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusionsQ42503598
TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutationsQ42509587
Distribution of basal ganglia lesions in generalized variant of Pick's disease: a clinicopathological study of four autopsy cases.Q42512593
Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159HisQ42631618
Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusionsQ46686145
Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological studyQ46850360
Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based studyQ48247819
Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B geneQ48428808
FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.Q48433435
Valosin-containing protein gene mutations: clinical and neuropathologic featuresQ48491139
Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration familyQ48558596
Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative studyQ48620412
Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.Q50414784
Frontotemporal dementia linked to chromosome 3 (FTD-3)--current concepts and the detection of a previously unknown branch of the Danish FTD-3 familyQ50547594
Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group.Q53342375
Distribution of cerebral cortical lesions in Pick's disease with Pick bodies: a clinicopathological study of six autopsy cases showing unusual clinical presentations.Q53350043
Frontotemporal dementiaQ56388056
Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusionsQ57306354
Frequency oftau mutations in three series of non-Alzheimer's degenerative dementiaQ57306412
Dementia lacking distinctive histology (DLDH) revisitedQ59549734
Frontotemporal lobar degeneration and ubiquitin immunohistochemistryQ59881380
A Reassessment of the Neuropathology of Frontotemporal Dementia Linked to Chromosome 3Q60597019
Frontotemporal dementiaQ79355717
TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLDQ81415911
P433issue1
P921main subjectfrontotemporal lobar degenerationQ18579
P304page(s)33-41
P577publication date2010-05-20
P1433published inActa NeuropathologicaQ343168
P1476titleFUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
P478volume120